tiprankstipranks
Trending News
More News >
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market

BridgeBio Oncology Therapeutics (BBOT) Ownership - Who Owns BridgeBio Oncology Therapeutics?

Compare
21 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
17,878,594Insider22.35%217,761,275
14,589,846Insider18.24%177,704,324
4,885,446Institution6.11%59,504,732
3,289,661Institution4.11%40,068,071
841,293Institution1.05%10,246,949
756,093Institution0.95%9,209,213
600,000Institution0.75%7,308,000
564,625Institution0.71%6,877,133
509,000Insider0.64%6,199,620
508,584Institution0.64%6,194,553

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
841,293Institution1.05%10,246,949
756,093Institution0.95%9,209,213
427,767Institution0.53%5,210,202
14,485Institution0.02%176,427
13,328Institution0.02%162,335

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
508,584Institution0.64%6,260,669
229,354Institution0.29%2,871,512
27,500Institution0.03%344,300

FAQ

Who Owns BridgeBio Oncology Therapeutics (BBOT)?
Currently, no data Available
What percentage of BridgeBio Oncology Therapeutics (BBOT) stock is held by institutional investors?
Currently, no data Available
What percentage of BridgeBio Oncology Therapeutics (BBOT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of BridgeBio Oncology Therapeutics (BBOT)?
Bihua Chen owns the most shares of BridgeBio Oncology Therapeutics (BBOT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.